VirTrial is a technology company using a stable, long-standing telehealth platform to transform the clinical trial industry. The platform offers a patient management program that combines video, text, and email allowing pharmaceutical companies and CROs to create patient centric trials by replacing some study visits with virtual visits. The vision is for 25-50% of the visits to be conducted virtually creating a hybrid model. The hybrid model is ideally suited for Phase III and Phase IV trials where patient compliance can be assessed and monitored from any location. Our post-approval patient management program allows sites to create efficient automated messaging for each study or patient group. The VirTrial app is supported on any device (Android, Apple, iPad, Computer) and can be used by any site. It is hosted in a secure, cloud-based, environment and is HIPAA compliant. VirTrial enables greater accessibility to trials for patients, higher performance by clinical trial sites, and improved outcomes for pharmaceutical companies. Working together we can bring better medications to market more quickly.